Apnimed Inc. (APMD) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Apnimed Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$19.15
−1.74% today
Market cap
$811M
Overall quality
46/100
Kronos AI 30-day
+28.2%
8 of 8 simulated paths end higher
Apnimed Inc. (APMD) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $811M. It trades at $19.15, down 1.74% today, at 4.7 times earnings. Its overall quality score is 46 out of 100, ranked against the whole US market. 4 analysts' average target of $50.33 implies +162.8% from today's price. Kronos AI's 30-day forecast is +28.2% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $50.33 |
| Low – high | $41.00 – $60.00 |
| Analysts | 4 |
| Upside to average | +162.8% |
Kronos AI 30-day forecast
| Expected close | $24.99 (+28.2%) |
| Likely range | +17.1% … +35.6% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 61 |
| Solvency | 43 |
| Growth | 35 |
| Overall | 46 |
| P/E | 4.7 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.